<?xml version="1.0" encoding="UTF-8"?>
<XML><RECORDS>
<RECORD>
	<REFERENCE_TYPE>31</REFERENCE_TYPE>
	<AUTHORS>
		<AUTHOR>Kawamori, D.</AUTHOR>
		<AUTHOR>Kurpad, A. J.</AUTHOR>
		<AUTHOR>Hu, J.</AUTHOR>
		<AUTHOR>Liew, C. W.</AUTHOR>
		<AUTHOR>Shih, J. L.</AUTHOR>
		<AUTHOR>Ford, E. L.</AUTHOR>
		<AUTHOR>Herrera, P. L.</AUTHOR>
		<AUTHOR>Polonsky, K. S.</AUTHOR>
		<AUTHOR>McGuinness, O. P.</AUTHOR>
		<AUTHOR>Kulkarni, R. N.</AUTHOR>
	</AUTHORS>
	<YEAR>2009</YEAR>
	<TITLE>Insulin signaling in alpha cells modulates glucagon secretion in vivo</TITLE>
	<SECONDARY_TITLE>Cell Metab</SECONDARY_TITLE>
	<VOLUME>9</VOLUME>
	<NUMBER>4</NUMBER>
	<PAGES>350-61</PAGES>
	<DATE>Apr</DATE>
	<ISBN>1932-7420 (Electronic)</ISBN>
	<ACCESSION_NUMBER>19356716</ACCESSION_NUMBER>
	<KEYWORDS>
		<KEYWORD>Animals</KEYWORD>
		<KEYWORD>Arginine/pharmacology</KEYWORD>
		<KEYWORD>Diabetes Mellitus, Experimental</KEYWORD>
		<KEYWORD>Fasting</KEYWORD>
		<KEYWORD>Feeding Behavior/drug effects</KEYWORD>
		<KEYWORD>Gene Expression Regulation/drug effects</KEYWORD>
		<KEYWORD>Glucagon/genetics/*secretion</KEYWORD>
		<KEYWORD>Glucagon-Secreting Cells/drug effects/pathology/*secretion</KEYWORD>
		<KEYWORD>Glucose Intolerance/complications</KEYWORD>
		<KEYWORD>Hyperinsulinism/complications/metabolism</KEYWORD>
		<KEYWORD>Hypoglycemia/complications/metabolism</KEYWORD>
		<KEYWORD>Insulin/genetics/*metabolism</KEYWORD>
		<KEYWORD>Insulin-Secreting Cells/drug effects/metabolism/pathology</KEYWORD>
		<KEYWORD>Mice</KEYWORD>
		<KEYWORD>Mice, Knockout</KEYWORD>
		<KEYWORD>Organ Size/drug effects</KEYWORD>
		<KEYWORD>Organ Specificity/drug effects</KEYWORD>
		<KEYWORD>Receptor, Insulin/deficiency/metabolism</KEYWORD>
		<KEYWORD>*Signal Transduction/drug effects</KEYWORD>
		<KEYWORD>Streptozocin</KEYWORD>
	</KEYWORDS>
	<ABSTRACT>Glucagon plays an important role in glucose homeostasis by regulating hepatic glucose output in both normo- and hypoglycemic conditions. In this study, we created and characterized alpha cell-specific insulin receptor knockout (alphaIRKO) mice to directly explore the role of insulin signaling in the regulation of glucagon secretion in vivo. Adult male alphaIRKO mice exhibited mild glucose intolerance, hyperglycemia, and hyperglucagonemia in the fed state and enhanced glucagon secretion in response to L-arginine stimulation. Hyperinsulinemic-hypoglycemic clamp studies revealed an enhanced glucagon secretory response and an abnormal norepinephrine response to hypoglycemia in alphaIRKO mice. The mutants also exhibited an age-dependent increase in beta cell mass. Furthermore, siRNA-mediated knockdown of insulin receptor in glucagon-secreting InR1G cells promoted enhanced glucagon secretion and complemented our in vivo findings. Together, these data indicate a significant role for intraislet insulin signaling in the regulation of alpha cell function in both normo- and hypoglycemic conditions.</ABSTRACT>
	<NOTES>5P30DK36836/DK/NIDDK NIH HHS/United StatesDK20593/DK/NIDDK NIH HHS/United StatesDK31842/DK/NIDDK NIH HHS/United StatesDK56341/DK/NIDDK NIH HHS/United StatesDK59637/DK/NIDDK NIH HHS/United StatesDK67536/DK/NIDDK NIH HHS/United StatesUL1RR024992/RR/NCRR NIH HHS/United StatesJournal ArticleResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tUnited States</NOTES>
	<URL>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19356716</URL>
</RECORD>
<RECORD>
	<REFERENCE_TYPE>31</REFERENCE_TYPE>
	<AUTHORS>
		<AUTHOR>Evgenov, N. V.</AUTHOR>
		<AUTHOR>Medarova, Z.</AUTHOR>
		<AUTHOR>Dai, G.</AUTHOR>
		<AUTHOR>Bonner-Weir, S.</AUTHOR>
		<AUTHOR>Moore, A.</AUTHOR>
	</AUTHORS>
	<YEAR>2006</YEAR>
	<TITLE>In vivo imaging of islet transplantation</TITLE>
	<SECONDARY_TITLE>Nat Med</SECONDARY_TITLE>
	<VOLUME>12</VOLUME>
	<NUMBER>1</NUMBER>
	<PAGES>144-8</PAGES>
	<DATE>Jan</DATE>
	<ISBN>1078-8956 (Print)</ISBN>
	<ACCESSION_NUMBER>16380717</ACCESSION_NUMBER>
	<KEYWORDS>
		<KEYWORD>Time Factors</KEYWORD>
		<KEYWORD>Phantoms, Imaging</KEYWORD>
		<KEYWORD>Microscopy, Fluorescence</KEYWORD>
		<KEYWORD>Microscopy, Electron/methods</KEYWORD>
		<KEYWORD>Microscopy, Confocal/methods</KEYWORD>
		<KEYWORD>Mice, Nude</KEYWORD>
		<KEYWORD>Mice</KEYWORD>
		<KEYWORD>Animals</KEYWORD>
		<KEYWORD>Magnetic Resonance Imaging/methods</KEYWORD>
		<KEYWORD>Islets of Langerhans Transplantation/*pathology</KEYWORD>
		<KEYWORD>Islets of Langerhans/*cytology</KEYWORD>
		<KEYWORD>Hyperglycemia</KEYWORD>
		<KEYWORD>Humans</KEYWORD>
		<KEYWORD>Enzyme-Linked Immunosorbent Assay</KEYWORD>
		<KEYWORD>Disease Models, Animal</KEYWORD>
		<KEYWORD>Diabetes Mellitus, Type 1/*pathology</KEYWORD>
		<KEYWORD>Diabetes Mellitus, Experimental</KEYWORD>
		<KEYWORD>Cell Transplantation</KEYWORD>
		<KEYWORD>Microscopy</KEYWORD>
		<KEYWORD>Fluorescence</KEYWORD>
		<KEYWORD>Disease Models</KEYWORD>
		<KEYWORD>Animal</KEYWORD>
		<KEYWORD>Diabetes Mellitus</KEYWORD>
		<KEYWORD>Phantoms</KEYWORD>
		<KEYWORD>Imaging</KEYWORD>
		<KEYWORD>Electron/methods</KEYWORD>
		<KEYWORD>Confocal/methods</KEYWORD>
		<KEYWORD>Nude</KEYWORD>
		<KEYWORD>Type 1/*pathology</KEYWORD>
		<KEYWORD>Experimental</KEYWORD>
	</KEYWORDS>
	<ABSTRACT>Type 1 diabetes mellitus is characterized by the selective destruction of insulin-producing beta cells, which leads to a deficiency in insulin secretion and, as a result, to hyperglycemia. At present, transplantation of pancreatic islets is an emerging and promising clinical modality, which can render individuals with type 1 diabetes insulin independent without increasing the incidence of hypoglycemic events. To monitor transplantation efficiency and graft survival, reliable noninvasive imaging methods are needed. If such methods were introduced into the clinic, essential information could be obtained repeatedly and noninvasively. Here we report on the in vivo detection of transplanted human pancreatic islets using magnetic resonance imaging (MRI) that allowed noninvasive monitoring of islet grafts in diabetic mice in real time. We anticipate that the information obtained in this study would ultimately result in the ability to detect and monitor islet engraftment in humans, which would greatly aid the clinical management of this disease.</ABSTRACT>
	<NOTES>DK071225/DK/NIDDK NIH HHS/United StatesJournal ArticleResearch Support, N.I.H., ExtramuralUnited States</NOTES>
	<URL>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16380717</URL>
</RECORD>
</RECORDS></XML>
